Johnson & Johnson
Heidi Landry is an accomplished procurement leader with extensive experience in the healthcare and chemical industries. Currently serving as Chief Procurement Officer for Johnson & Johnson MedTech since January 2019, Heidi oversees a $28 billion procurement operation and leads a global team of 500 professionals managing a network of 12,000 suppliers across 58 manufacturing sites. Prior to this role, Heidi held various significant positions, including Director of Raw Materials, Packaging & External Manufacturing at The Dow Chemical Company, where responsibilities included driving synergies of $415 million during the Dow-Dupont merger, and VP of Procurement at Dow Corning. With additional experience at Novartis, IKEA, Kmart, and Baird Corp, Heidi's educational background includes a B.A. in International Trade/Economics from the University of Massachusetts Amherst, advanced studies in Finance at Harvard University, and ongoing executive programs at Harvard Business School and MIT Sloan School of Management.
Johnson & Johnson
541 followers
Johnson & Johnson and its subsidiaries have approximately 141,700 employees worldwide engaged in the research and development, manufacture and sale of a broad range of products in the healthcare field. Johnson & Johnson is a holding company, with operating companies conducting business in virtually all countries of the world. The Company’s primary focus is products related to human health and well-being. Johnson & Johnson was incorporated in the State of New Jersey in 1887. Johnson & Johnson is organized into three business segments: Consumer Health, Pharmaceutical and Medical Devices. The Consumer Health segment includes a broad range of products focused on personal healthcare used in the Skin Health/Beauty, Over-the-Counter medicines, Baby Care, Oral Care, Women’s Health and Wound Care markets. The Pharmaceutical segment is focused on six therapeutic areas: Immunology (e.g., rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease and psoriasis), Infectious Diseases (e.g., HIV/AIDS and COVID-19), Neuroscience (e.g., mood disorders, neurodegenerative disorders and schizophrenia), Oncology (e.g., prostate cancer, hematologic malignancies, lung cancer and bladder cancer), Cardiovascular and Metabolism (e.g., thrombosis, diabetes and macular degeneration) and Pulmonary Hypertension (e.g., Pulmonary Arterial Hypertension). Medicines in this segment are distributed directly to retailers, wholesalers, distributors, hospitals and healthcare professionals for prescription use. The Medical Devices segment includes a broad range of products used in the Interventional Solutions, Orthopaedics, Surgery, and Vision fields. At Johnson & Johnson, employees are guided by Our Credo which sets forth the Company’s responsibilities to patients, consumers, customers, healthcare professionals, employees, communities and shareholders. The Company is committed to workplace diversity and to cultivating, fostering, and advancing a culture of equity and inclusion. Enabling employees to perform at their best while being themselves is fundamental to the Company’s continued success. The Company’s DEI vision is: Be yourself, change the world.